Nabiximols Improve Spasticity Symptoms in Motor Neuron Disease

From Neurology Advisor: Nabiximols, a cannabidiol, reduced spasticity symptoms and was tolerable and safe when used in patients with motor neuron disease, according to a phase 2 trial published in Lancet Neurology. In this randomized, double-blind study ( identifier: NCT01776970), patients with possible, probable, or definite amyotrophic lateral sclerosis orRead More →